Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 1 | -5.30 | 298.2392 | 0.073 | 0.94086 | 0.48387 | |||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 6 | -5.73 | 240.3203 | 0.808 | 0.91922 | 0.84401 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 5 | -6.31 | 302.5813 | 0.872 | 0.90672 | 0.84816 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -5.57 | 236.0268 | 0.848 | 0.90179 | 0.77679 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 1 | -4.70 | 139.7368 | 0.011 | 0.92026 | 0.78469 | |||
| HeLa ICRP | Mapatumumab | 2.5 | nM | anti-Fc | 2.5 | nM | 1 | -5.02 | 168.6104 | 0.582 | 0.83117 | 0.71688 | ||||||
| HeLa ICRP | Mapatumumab | 2.5 | nM | anti-Fc | 2.5 | nM | 2 | -5.14 | 181.8431 | 0.494 | 0.90000 | 0.78824 | ||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 2 | -4.93 | 153.1692 | 0.347 | 0.89079 | 0.76445 | ||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 3 | -4.94 | 145.1482 | 0.550 | 0.82210 | 0.67925 | ||||||
| HeLa ICRP | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 3 | -4.68 | 110.9162 | 0.288 | 0.84817 | 0.79581 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -4.50 | 85.1585 | 0.268 | 0.73592 | 0.70775 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 7.5 | ng/ml | 1 | -5.38 | 333.0821 | 0.012 | 0.94807 | 0.44891 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 5.0 | ng/ml | 3 | -5.79 | 469.2892 | 0.407 | 0.88235 | 0.52941 | ||||||
| HeLa ICRP | TNF10 | 50.0 | ng/ml | 2 | -4.86 | 168.6667 | 0.276 | 0.84286 | 0.74286 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 5.0 | ng/ml | 2 | -5.53 | 404.8037 | 0.065 | 0.83770 | 0.38743 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 5.0 | ng/ml | 1 | -5.56 | 416.4737 | 0.358 | 0.94737 | 0.58947 | ||||||
| HeLa ICRP | TNF10 | 50.0 | ng/ml | 1 | -4.71 | 138.0000 | 0.400 | 0.68889 | 0.60000 | |||||||||
| HeLa ICRP | TNF10 | 7.5 | ng/ml | 1 | -5.81 | 277.9023 | 0.825 | 0.92241 | 0.85057 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 1.0 | ng/ml | 2 | -6.32 | 468.5230 | 0.965 | 0.99344 | 0.91028 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 1.0 | ng/ml | 1 | -6.43 | 491.0887 | 1.000 | 0.99194 | 0.96774 | ||||||
| HeLa ICRP | TNF10 | 25.0 | ng/ml | 3 | -5.47 | 227.5857 | 0.726 | 0.92000 | 0.80000 | |||||||||
| HeLa ICRP | TNF10 | 500.0 | ng/ml | 4 | -4.31 | 68.7177 | 0.082 | 0.88147 | 0.86207 | |||||||||
| HeLa ICRP | Navitoclax | 10 | uM | TNF10 | 500.0 | ng/ml | 1 | -4.30 | 54.0650 | 0.013 | 0.98211 | 0.80813 | ||||||
| HeLa ICRP | Navitoclax | 10 | uM | TNF10 | 250.0 | ng/ml | 3 | -4.17 | 41.8056 | 0.039 | 0.93333 | 0.74722 | ||||||
| HeLa ICRP | TNF10 | 500.0 | ng/ml | 3 | -4.26 | 58.7068 | 0.046 | 0.90595 | 0.86030 |